SPRY
ARS Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.62
−0.88%Leverage
- Debt / equity
- 13.72x
- Net debt / equity
- 13.06x
- Debt / assets
- 0.69x
- Debt / EBITDA
- -0.83x
- Net debt / EBITDA
- -0.79x
Liquidity & coverage
- Current ratio
- 3.48x
- Quick ratio
- 3.28x
- Cash ratio
- 2.36x
- Interest coverage
- -43.96x
- EBITDA / interest
- -42.08x
- Working capital
- $150.6M
Cash & dividend
- FCF / debt
- -1.15x
- Cash flow / debt
- -1.14x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026